Skip to main content
Clinical Trials/NCT01525420
NCT01525420
Completed
Not Applicable

Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy

Fred Hutchinson Cancer Center1 site in 1 country121 target enrollmentMarch 2012
ConditionsSmoking

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Smoking
Sponsor
Fred Hutchinson Cancer Center
Enrollment
121
Locations
1
Primary Endpoint
Number of Participants Who Stopped Smoking by 6 Month Post Treatment
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).

Implementation outcomes:

  • end of treatment and 6-month follow-up data retention rates;
  • intervention implementation quality;
  • number & length of calls completed.

Comparison of each arm's implementation

Registry
clinicaltrials.gov
Start Date
March 2012
End Date
March 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jonathan Bricker

Associate Member, Public Health Sciences

Fred Hutchinson Cancer Center

Eligibility Criteria

Inclusion Criteria

  • aged 18 and older;
  • smokes at least 10 cigarettes daily and has done so for at least the past 12 months;
  • wants to quit smoking in the next 30 days;
  • willing to be randomly assigned to either group;
  • willing and able to speak and read in English;
  • willing and medically eligible to use nicotine replacement therapy (NRT),
  • currently resides in the U.S., and expects to continue for at least 12 months;
  • not participating in other smoking cessation interventions;
  • has regular access to a telephone.
  • has regular access to an email address.

Exclusion Criteria

  • The Exclusion criteria are the opposite of the Inclusion criteria listed above. In addition, the following exclusion criteria also apply:
  • another member of household enrolled in the study;
  • currently using medication or nicotine replacement products to help with quitting smoking;
  • currently using any non-cigarette tobacco products;
  • pregnant or breastfeeding;
  • had a heart attack in last 30 days;
  • within the last 6 months, diagnosed with angina, heart pain, or irregular heartbeat;
  • serious adverse reactions to nicotine patches including anaphylaxis and related symptoms such as hives, respiratory difficulty, and/or angioedema.

Outcomes

Primary Outcomes

Number of Participants Who Stopped Smoking by 6 Month Post Treatment

Time Frame: 6 months

30-Day point prevalence abstinence at 6 months post treatment

Secondary Outcomes

  • 7-day and 24-hour Point Prevalence Quit Rates(6-month)

Study Sites (1)

Loading locations...

Similar Trials